|

Standard Therapy Clinical Trials

5 actively recruiting trials across 1 location

Also known as: Azacitidine + venetoclax for AML patients. Azacitidine for MDS patients., Paclitaxel (Taxol); Doxorubicin (Adriamycin), TCbHP, THP, EC-THP, AC-THP

Other4 trials

Clinical Outcome of Vinpocetine in Diabetic Nephropathy
Phase 2/3
MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
Phase 2
Precision Therapy Versus Standard Therapy in AML and MDS in Elderly
Phase 2
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.

Birmingham, Alabama1 trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.